Skip Internal Navigation
The CDDB, formerly the Contraception and Reproductive Health Branch, develops and supports research and research training programs in contraceptive development, pelvic floors disorders and other areas of reproductive health. Major research areas include studies of: new contraceptive methods; mechanisms of action and effects of contraceptive and reproductive hormones, drugs, devices, and procedures as well as optimal formulations and dosages of contraceptive agents and spermicidal microbicides.
- Branch-supported finding:
- Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST, Bremner WJ, Sitruk-Ware R, Kumar N, Blithe DL, & Wang C. (2012). A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab, 97(10), 3476-3486. PMID: 22791756
- Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, & Gainer E. (2010). Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet,375(9714), 555-562. PMID:20116841
- Burke AE, Barnhart K, Jensen JT, Creinin MD, Walsh TL, Wan LS, Westhoff C, Thomas M, Archer D, Wu H, Liu J, Schlaff W, Carr BR, Blithe D. (2010). Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial. Obstet Gynecol, Dec;116(6), 1265-1273. PMID:21099590
- Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, Gainer E, & Ulmann A. (2011). Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception, 84(4), 363-367. PMID: 21920190
- Branch-supported network: